Human placental alkaline phosphatase in benign and malignant ovarian neoplasia.

In benign and malignant ovarian tumor patients, human placental alkaline phosphatase (HPLAP) was determined in serum and extracts from surgical tumor biopsies using a highly specific enzyme-antigen immunoassay based on a mouse monoclonal antibody (E6) to HPLAP. Serum HPLAP levels greater than or equal to 0.1 unit/liter were found in 58% of ovarian cancer patients.

Enzyme-antigen immunoassay for human placental alkaline phosphatase in serum and tissue extracts, and its application as a tumor marker.

In this enzyme-antigen immunoassay for human placental alkaline phosphatase (hPLAP; EC 3.1.3.

Paraquat poisoning.

A fatal case of paraquat poisoning is described. Postmortem concentration of paraquat in different tissues reveals that treatment in this case could not prevent lethal tissue accumulation. Although accumulation was more pronounced in renal tissue, lung toxicity caused death.

Unipuncture membrane plasmapheresis.

A simple method of plasma exchange is presented that uses a hollow-fiber plasma filter together with conventional unipuncture dialysis equipment. The procedure was well tolerated for eight biweekly sessions in a patient with metastatic breast cancer.

Autogenous saphenous vein AV fistulae for haemodialysis: eight years experience with 30 patients.

Since 1973, 41 autogenous saphenous vein (ASV) fistulae in the arm or the leg have been constructed in 30 chronic haemodialysis patients. The mean patency rate for the arm fistulae was 36.8 months and 21.